A. Gourlaouen

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

Anti-inflammatory drugs and variceal bleeding: a case-control study

V. de Lédinghen, D. Heresbach, P. Ingrand, 1999, Gut.

Sclerotherapy with or without octreotide for acute variceal bleeding.

D. Heresbach, P. Ingrand, M. Becker, 1995, The New England journal of medicine.

Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.

J. Douillard, J. Metges, Z. Alavi, 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

PANERB study: Panitumumab after cetuximab-based regimen failure.

J. Douillard, J. Raoul, J. Metges, 2010 .

[Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases)].

J. Cauvin, J. Nousbaum, H. Gouérou, 1993, Gastroenterologie clinique et biologique.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

J. Douillard, P. Langlet, E. Jobard, 2014, Oncologie.